Business · 28/01/2005Updated: 10/17/2026 · 1 min read
FDA Announces Hearing Opportunity for Withdrawal of 13 New Drug Applications
Summary
The Food and Drug Administration (FDA) is seeking public input on its proposal to withdraw approval of 13 new drug applications from multiple pharmaceutical companies, citing repeated failure to submit required annual reports.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →